Nimotuzumab Biosimilar - Research Grade,ichor.bio,ICH4008
Detects human EGFR. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Nimotuzumab.
Host
Humanized
Reactivity
Human
Platform ID
BAB012925500
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameNimotuzumab Biosimilar - Research Grade
Cat. No.ICH4008
Accession NumberP00533
HostHumanized
IsotypeHuman IgG1 Kappa
ReactivityHuman
Concentration1.0 - 5.0 mg/ml
TargetEGFR
Purity>95% by SDS-PAGE and HPLC
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml
ICH3002-100ml
ICH3003-100ml
StorageStable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory StatusFor research use only
Scientific Background
Nimotuzumab biosimilar has a humanized human-mouse h-R3 heavy chain and a humanized human-mouse h-R3_-chain. nimotuzumab binds to the epidermal growth factor receptor (EGFR), a signalling protein that normally controls cell division.
Synonyms
Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.